Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Clinical Medicine|September 27, 2025
Diagnostic Biomarkers for Risk Estimation of In-Hospital and Post-Discharge Cardiovascular Mortality in ST-Segment Elevation Myocardial Infarction (STEMI) PatientsKristen Kopp, Michael Lichtenauer, Vera Paar, et al.
Biomedicines|November 11, 2022
Investigation of hs-TnI and sST-2 as Potential Predictors of Long-Term Cardiovascular Risk in Patients with Survived Hospitalization for COVID-19 PneumoniaLukas Fiedler, Lukas J Motloch, Peter Jirak, et al.
Frontiers in Medicine|July 15, 2022
Cardiovascular Biomarkers for Prediction of in-hospital and 1-Year Post-discharge Mortality in Patients With COVID-19 PneumoniaLukas J Motloch, Peter Jirak, Diana Gareeva, et al.
Journal of Personalized Medicine|May 28, 2022
Gender-Specific Differences in the Intensive Care Treatment of COVID-19 PatientsPeter Jirak, Moritz Mirna, Vincent Van Almsick, et al.
Journal of Clinical Medicine|March 28, 2020
Novel Biomarkers in Patients with Chronic Kidney Disease: An Analysis of Patients Enrolled in the GCKD-StudyMoritz Mirna, Albert Topf, Bernhard Wernly, et al.
Frontiers in Pharmacology|December 11, 2023
Hypertrophic cardiomyopathy is characterized by alterations of the mitochondrial calcium uniporter complex proteins: insights from patients with aortic valve stenosis versus hypertrophic obstructive cardiomyopathyVera Paar, Michael Haslinger, Philipp Krombholz-Reindl, et al.
Frontiers in Pharmacology|June 16, 2023
Prophylactic rivaroxaban in the early post-discharge period reduces the rates of hospitalization for atrial fibrillation and incidence of sudden cardiac death during long-term follow-up in hospitalized COVID-19 survivorsLukas Fiedler, Lukas J Motloch, Anna-Maria Dieplinger, et al.
Frontiers in Cardiovascular Medicine|August 15, 2022
Early antithrombotic post-discharge therapy using prophylactic DOAC or dipyridamole improves long-term survival and cardiovascular outcomes in hospitalized COVID-19 survivorsLukas J Motloch, Peter Jirak, Moritz Mirna, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 19, 2024
Impact of empagliflozin on cardiac structure and function assessed by echocardiography after myocardial infarction: a post-hoc sub-analysis of the emmy trialNora Schwegel, Christoph Strohhofer, Ewald Kolesnik, et al.
Plos One|October 14, 2021
J-waves in acute COVID-19: A novel disease characteristic and predictor of mortality?Naufal Shamilevich Zagidullin, Lukas J Motloch, Timur Ilgamovich Musin, et al.
Pageof 3